Stonegate Capital Partners Updates Coverage on Burcon Nutrascience Corporation (TSX: BU) 1Q26
During 1Q26, Burcon advanced meaningfully in its commercialization strategy. Within 90 days of commissioning its Galesburg facility, the Company achieved first commercial production of its next-generation Peazazz® C pea protein and debuted FavaPro™ fava protein. Initial shipments of Peazazz® C were completed during the quarter, supported by strong market reception and customer trials. Burcon also […]
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (NASDAQ: ACOG) 2Q25
Alpha Cognition advanced its first full quarter of ZUNVEYL® commercialization in 2Q25, driving meaningful early adoption in the U.S. long-term care (LTC) market and securing a key regulatory milestone in China. By quarter-end, ZUNVEYL (benzgalantamine) had been ordered in over 300 LTC facilities across priority regions, with 65% placing repeat orders, signaling strong clinical confidence […]
Stonegate Capital Partners Updates Coverage On Surf Air Mobility Inc. (NYSE: SRFM) 2Q25
SRFM reported revenue, Adj. EBITDA, and Adj. EPS of $27.4M, ($9.5)M, and ($1.34), respectively, exceeding both revenue and EBITDA guidance for the quarter. This performance reflects a clear inflection point for the Company, driven by improved airline operations, continued optimization of the On Demand segment, and growing momentum in its SurfOS software platform. Notably, airline […]
Stonegate Capital Partners Updates Coverage on Sky Harbour Group Corporation (NYSE: SKYH) 2Q25
Sky Harbour maintained strong operational momentum in 2Q25, underpinned by campus openings, leasing activity, and construction progress across its growing nationwide network. During the quarter, the Company commenced operations at Dallas Addison (ADS) and Seattle Boeing Field (BFI) and prepared for the start of resident flight operations at Denver Centennial (APA) in early 3Q25. Miami […]
Stonegate Capital Partners Updates Coverage on Valens Semiconductor Ltd. (NYSE:VLN) 2Q25
Valens Semiconductor posted 2Q25 revenue of $17.1M, above guidance of $16.5– $16.8M, marking its fifth consecutive quarter of growth and up from $16.8M in 1Q25 and $13.6M in 2Q24. GAAP gross margin was 63.5% (non-GAAP 67.2%), within guidance and up from 62.9% in 1Q25. Adjusted EBITDA loss of $(4.0)M was better than the expected $(4.9)–$(4.4)M […]
Stonegate Capital Partners Updates Coverage On GoHealth Inc. (NASDAQ: GOCO) 2Q25

GoHealth, Inc. delivered a challenged second quarter in 2025, highlighted by revenue declines and contracting margins.
Stonegate Capital Partners Updates Coverage on Metallus Inc (NYSE: MTUS) 2Q25
Metallus delivered another quarter of sequential improvement in Q2 2025, with continued strength in shipments and profitability. Net sales increased 8.6% q/q and 3.4% y/y to $304.6M, driven by higher volumes and increased surcharge revenue. Adjusted EBITDA rose to $26.5M, up from $17.7M in 1Q25 and $19.9M in the prior year, supported by improved melt […]
Stonegate Updates Coverage on Information Services Group Inc. Common Stock (NasdaqGM: III) 2Q25
III Revenue for the second quarter totaled $61.6M, up 7% year-over-year when excluding the divested automation unit, exceeding guidance. Excluding prior-year contributions from the divested automation business, segment revenue in the Americas increased to $39.5M, representing growth of 16% y/y. Despite macro uncertainty and softer demand in Europe and Asia-Pacific, the Company drove margin expansion […]
Stonegate Capital Partners Updates Coverage on Gladstone Commercial Corp. (NasdaqGS: GOOD) 2Q25
In the second quarter of 2025, Gladstone Commercial Corp. maintained its disciplined portfolio management approach. The Company ended the quarter with 143 properties across 27 states, expanding its footprint from the previous quarter. During 2Q25, GOOD executed its capital recycling strategy by selling two non-core properties, for a combined $23.6M. Additionally, the Company expanded its […]
Stonegate Capital Partners Updates Coverage on BlackSky Technology Inc. (NYSE: BKSY) 2Q25
BKSY reported revenue, adj EBITDA, and EPS of $22.2M, ($2.8)M, and ($1.27), respectively. This compares to our/consensus estimates of $22.2M/$22.2M, ($1.5)M/($1.3)M, and ($0.48)/($0.48). Imagery and Software Analytical Services revenue increased to $18.0M, up 2.9% y/y, reflecting growing demand and early access activity related to Gen-3 imagery. Professional and Engineering Services revenue declined to $4.2M from […]